featured
Evolocumab Reduces Lipoprotein Levels but Not Arterial Wall Inflammation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Heart Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Persistent Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) Despite Strong Low-Density Lipoprotein Cholesterol Reduction by Proprotein Convertase Subtilisin/Kexin Type 9 Antibody Treatment
Eur Heart J 2018 Dec 18;[EPub Ahead of Print], LCA Stiekema, ESG Stroes, SL Verweij, H Kassahun, L Chen, SM Wasserman, MS Sabatine, V Mani, ZA FayadFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.